| Biomarker ID | 1287 |
| PMID | 24391718 |
| Year | 2013 |
| Biomarker | PDCD6IP; EEF1A2; FASN; UBA52; VPS28; ACTR3B; BCAM; CD9;YWHAB; ANXA2; ATP1A1; ATP1B1; ATP1B3; BSG; CLIC1; ITGA6; F11R; ACTA2; HSPA5; YWHAQ; CD151; PTGFRN; HBB; RAC1; |
| Biomarker Basis | Expression Based |
| Biomolecule | Protein |
| Source | Cell Lines |
| Subjects | Humans |
| Regulation | Upregulated in VCaP cell lines (log2 fold): Downregulated in VCaP cell lines (log2 fold): [] |
| Odds Ratio/Hazard Ratio/Relative Risk | NA |
| Effect on Pathways | NA |
| Experiment | VCaP vs RWPE |
| Type of Biomarker | Diagnostic |
| Cohort | 2 immortalized primary prostate epithelial cells (PNT2C2 and RWPE- 1) and 2 PCa cell lines (PC346C and VCaP) were chosen for this study |
| Senstivity | NA |
| Specificity | NA |
| AUC | NA |
| Accuracy | NA |
| Level Of Significance | p<0.05 |
| Method Used | Mass spectrometry |
| Clinical | No |
| Remarks | NA |
| Clinical Trial Number | NA |
| Degree Of Validity | Selected Genes validated on cell lines by Western Blotting |
| Technical Name | PDCD6IP, EEF1A2, FASN, UBA52, VPS28, ACTR3B, BCAM, CD9, YWHAB, ANXA2, ATP1A1, ATP1B1, ATP1B3, BSG, CLIC1, ITGA6, F11R, ACTA2, HSPA5, YWHAQ, CD151, PTGFRN, HBB, RAC1 |